OTCMKTS:AXIM AXIM Biotechnologies (AXIM) Stock Price, News & Analysis $0.01 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.0132▼$0.014950-Day Range$0.0068▼$0.015052-Week Range$0.01▼$0.03Volume52,069 shsAverage Volume365,227 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get AXIM Biotechnologies alerts: Email Address Ad Traders Agency5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.Click here to pay just $5 for a full year of Stealth Trades About AXIM Biotechnologies Stock (OTCMKTS:AXIM)AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.Read More AXIM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AXIM Stock News HeadlinesMay 29, 2024 | finance.yahoo.comAXIM Biotechnologies Receives Medical Device Manufacturing LicenseMay 25, 2024 | finance.yahoo.comAXIM Biotechnologies, Inc. (AXIM)July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 24, 2024 | msn.comQueenmother of Upper Axim recognised for contributions towards educationMay 11, 2024 | morningstar.comAXIM Biotechnologies Inc AXIMApril 18, 2024 | seekingalpha.comADPT Adaptive Biotechnologies CorporationApril 4, 2024 | msn.comAxim youth appeal for sports infrastructureMarch 27, 2024 | globenewswire.comVIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.March 7, 2024 | msn.comWe Want Peaceful Elections – Axim YouthFebruary 20, 2024 | finance.yahoo.comAXIM® Biotechnologies’ Tear Based Testing Platform Continues to Gain Traction After Successful Clinical ValidationFebruary 20, 2024 | globenewswire.comAXIM® Biotechnologies' Tear Based Testing Platform Continues to Gain Traction After Successful Clinical ValidationFebruary 7, 2024 | msn.comAxim Fishermen Hail GovtFebruary 6, 2024 | msn.comMASLOC Trial: Daniel Axim Denies ChargesDecember 21, 2023 | msn.comAXIM and Auer partner for dry eye disease assay productionDecember 20, 2023 | finance.yahoo.comAXIM® Biotechnologies Partners With Leading Diagnostic Manufacturer Auer Precision to Scale Assay ProductionDecember 11, 2023 | msn.comTullow builds 14-unit dormitory block for Axim Girls SHSDecember 2, 2023 | seekingalpha.comLLBO Lifeline Biotechnologies, Inc.See More Headlines Receive AXIM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AXIM Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:AXIM CUSIPN/A CIK1514946 Webaximbiotech.com Phone(858) 923-4422FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. John W. Huemoeller II (Age 69)President, CEO & Director Comp: $420kMr. Robert T. Malasek (Age 56)CFO & Secretary Comp: $90kMs. Catalina Valencia J.D. (Age 75)Co-Founder & CEO of Sapphire Biotech, Inc. Comp: $187.5kMr. Kurt Phinney (Age 51)Chief Operating Officer Dr. Sergei A. Svarovsky M.B.A.Ph.D., Chief Scientific Officer & Co-Founder of Sapphire Biotech, Inc.Dr. Douglas Lake Ph.D.Chief Clinical Officer of Sapphire Biotech, Inc.Dr. Alim Seit-Nebi Ph.D.CTO & Co-Founder of Sapphire Biotech, Inc.Mr. Jeffrey A. BusbySenior Vice President of Business DevelopmentDr. Joseph Tauber M.D. (Age 67)Chief Medical Officer & Chairman of the Medical Advisory Board Dr. Maria J. Gonzalez Moa Ph.D.Vice President of Product Development - Sapphire Biotech, Inc.More ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors AXIM Stock Analysis - Frequently Asked Questions How have AXIM shares performed this year? AXIM Biotechnologies' stock was trading at $0.0190 at the beginning of the year. Since then, AXIM stock has decreased by 22.1% and is now trading at $0.0148. View the best growth stocks for 2024 here. How do I buy shares of AXIM Biotechnologies? Shares of AXIM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of AXIM Biotechnologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that AXIM Biotechnologies investors own include Cronos Group (CRON), Tilray (TLRY), KushCo (KSHB), Curaleaf (CURLF). This page (OTCMKTS:AXIM) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AXIM Biotechnologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AXIM Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.